EUVIMEDEUVIMED entdecken
Fallbericht

KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features

Farhan Hassan, Hailing Zhang, Dietrich Werner Idiaquez, Nagehan Pakasticali, Elizabeth Hyjek, Mohammad Hussaini iD

American Journal of Clinical Pathology · 2025

DOI: 10.1093/ajcp/aqaf041 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Farhan Hassan und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri-Kansas City (UMKC) College of Medicine, Kansas City, MO, United States. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Histiocytic Sarcoma, Proto-Oncogene Proteins p21(ras), Dendritic Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We sought to investigate the molecular mechanism underlying transformation of chronic lymphocytic leukemia (CLL) to histiocytic sarcoma (HS) with indeterminate dendritic cell (IDC) features.

Methods

Extensive NGS-based genomic profiling was performed on samples of a patient who had CLL, secondary HS with IDC features, and CMML. Clonotypic evaluation of VDJ rearrangement status was performed to confirm clonal relatedness.

Results

HS is a rare proliferation of malignant tissue histiocytes that is usually primary, although secondary HS exists and often demonstrates mutations in the Ras/Raf/MAPK or PI3K/AKT/mTOR pathways, but HS with indeterminate dendritic cell (IDC) features has not been previously reported. A 77-year-old man with chronic lymphocytic leukemia (CLL) presented with an oropharyngeal mass. Biopsy specimen showed large atypical histiocytic cells with oval-to-irregular indented nuclei. They were positive for CD33, CD4, CD68 (subset, weak), CD163 (subset, weak), BCL6, S100 (subset), CD1a, cyclin D1 (subset), and lysozyme (weak) but negative for Langerin, BRAF V600E, CD21, CD23, CD35, CD123, TCF4, TCL1, MPO, CD20, CD79a, CD10, MUM1, and BCL2. The patient was diagnosed with secondary HS with IDC features as well as chronic myelomonocytic leukemia (CMML) in the bone marrow. Careful genomic dissection of all 3 types of malignant cells showed that SF3B1 p.E622D was present in both CLL and HS but not CMML. In addition, the HS acquired KRAS p.G13D, which we hypothesize drove the transdifferentiation of CLL to HS. Moreover, next-generation sequencing (NGS) clonotypic evaluation of variable-diversity-joining (VDJ) rearrangements in both the HS and CLL established relatedness but not the CMML.

Conclusion

This is the first report of secondary HS with IDC features arising from CLL. We establish by both IGH NGS analysis and mutational profiling that the CLL and HS are clonally-related and posit that acquisition of KRAS p.G13D drove transdifferentiation. This has therapeutic implications for targeting the RAS-BRAF-MAPK-ERK pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellHistiocytic SarcomaProto-Oncogene Proteins p21(ras)Dendritic CellsCell Transformation, NeoplasticHumansMaleAgedMutationBiomarkers, Tumor

Stichwörter der Autor:innen

KRASchronic lymphocytic leukemiahistiocytic sarcomatransdifferentiation

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • University of Missouri-Kansas City (UMKC) College of Medicine, Kansas City, MO, United States.
  • Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

ORCID-Profile: Mohammad Hussaini

Zitieren

APA

Hassan, F., Zhang, H., Idiaquez, D. W., Pakasticali, N., Hyjek, E., & Hussaini, M. (2025). KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf041

Vancouver

Hassan F, Zhang H, Idiaquez DW, Pakasticali N, Hyjek E, Hussaini M. KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf041

BibTeX
@article{Hassan2025,
  author = {Hassan, Farhan and Zhang, Hailing and Idiaquez, Dietrich Werner and Pakasticali, Nagehan and Hyjek, Elizabeth and Hussaini, Mohammad},
  title = {KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features},
  journal = {American Journal of Clinical Pathology},
  year = {2025},
  doi = {10.1093/ajcp/aqaf041}
}
Kostenlos starten →